United States · FDA National Drug Code directory
LOTEMAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-503_253b0a9d-16fe-2eb1-e063-6294a90ac5e0
- Product NDC
- 24208-503
- Form
- GEL
- Composition / generic term
- loteprednol etabonate
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20121012
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (24208-503-07) / 5 g in 1 BOTTLE · 24208-503-07
- 1 BOTTLE in 1 CARTON (24208-503-48) / .5 g in 1 BOTTLE · 24208-503-48
- 1 BOTTLE in 1 CARTON (24208-503-96) / 5 g in 1 BOTTLE · 24208-503-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →